Open AccessCOVID-19 and fatal renal mucormycosis: Contributory or coincidental?
Author(s) -
Gautam Ram Choudhary,
Amit Aggarwal,
Vidhi Jain,
Rahul Jena
Publication year - 2021
Publication title -
indian journal of urology/indian journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.333
H-Index - 30
eISSN - 1998-3824
pISSN - 0970-1591
DOI - 10.4103/iju.iju_197_21
Subject(s) - mucormycosis , medicine , covid-19 , disease , immune dysregulation , presentation (obstetrics) , renal transplant , mechanical ventilation , intensive care medicine , dermatology , pathology , kidney , surgery , infectious disease (medical specialty)
Association of mucormycosis with COVID-19 disease is emerging as a matter of concern, with multiple reports of rhino-cerebral-orbital and pulmonary involvement. The association of isolated renal mucormycosis in a patient with a history of COVID-19 infection is unknown. The immune dysregulation associated with COVID, along with the use of steroids, mechanical ventilation, and interleukin-6-directed therapies, predisposes to the development of mucormycosis. We report a rare case of primary renal mucormycosis in a young male following recovery from COVID-19. The unusual mode of presentation, rapidly progressive disease course, and the ensuing dilemmas in diagnosis and treatment merit critical analysis.